Roche has received US Food and Drug Administration (FDA) clearance for its Accu-Chek Aviva Plus test strip.
The new maltose-independent test strip is designed to prevent the interference of maltose on blood sugar readings.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Accu-Chek Aviva Plus test strip helps patients self-monitor blood glucose and can be used with the Accu-Chek Aviva system.
Roche Diagnostics COO Daniel Day said the new test strips will help support patients to self-monitor their blood glucose effectively.
GlobalData Strategic Intelligence
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
